{
  "ptid_time": "002_S_2073_2016-10-03",
  "img_path": "/data/qiuhui/data/adni/images/002_S_2073/2016-10-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 27,535 mm³, 23.3% above the reference mean. With a Z-score of 0.58 (72.0th percentile), this represents normal volume ; hippocampal volume measures 6,596 mm³, 14.2% below the reference mean. With a Z-score of -1.59 (5.6th percentile), this represents moderate atrophy; whole brain volume measures 1,030,110 mm³, 0.1% above the reference mean. With a Z-score of 0.01 (50.5th percentile), this represents normal volume ; entorhinal cortex volume measures 4,764 mm³, 22.4% above the reference mean. With a Z-score of 1.73 (95.9th percentile), this represents moderate enlargement; fusiform gyrus volume measures 18,298 mm³, 0.5% above the reference mean. With a Z-score of 0.05 (52.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,260 mm³, 6.1% below the reference mean. With a Z-score of -0.55 (29.3th percentile), this represents normal volume . ",
  "text_data": "Age is 69.4 years. Gender is Female. Education: 20 years. MMSE: 29.0. MoCA: 26.0. Logical Memory: 21.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.36 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows moderate atrophy (Z-score -1.59, 5.6th percentile), which is a strong biomarker for Alzheimer's pathology, while other brain regions are largely normal. The MMSE (29) is normal, but the MoCA (26) suggests mild cognitive inefficiency, possibly early impairment. Elevated AV45 (amyloid PET) indicates amyloid pathology, supporting an Alzheimer's process despite the absence of APOE4.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **Medium** (clinical scores are borderline, but hippocampal atrophy + amyloid positivity suggest early disease)",
  "timestamp": "2025-07-25T20:19:59.568696"
}